Literature DB >> 18935984

Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease.

Karina Acevedo-Torres1, Lexsy Berríos, Nydia Rosario, Vanessa Dufault, Serguei Skatchkov, Misty J Eaton, Carlos A Torres-Ramos, Sylvette Ayala-Torres.   

Abstract

Many forms of neurodegeneration are associated with oxidative stress and mitochondrial dysfunction. Mitochondria are prominent targets of oxidative damage, however, it is not clear whether mitochondrial DNA (mtDNA) damage and/or its lack of repair are primary events in the delayed onset observed in Huntington's disease (HD). We hypothesize that an age-dependent increase in mtDNA damage contributes to mitochondrial dysfunction in HD. Two HD mouse models were studied, the 3-nitropropionic acid (3-NPA) chemically induced model and the HD transgenic mice of the R6/2 strain containing 115-150 CAG repeats in the huntingtin gene. The mitochondrial toxin 3-NPA inhibits complex II of the electron transport system and causes neurodegeneration that resembles HD in the striatum of human and experimental animals. We measured nuclear and mtDNA damage by quantitative PCR (QPCR) in striatum of 5- and 24-month-old untreated and 3-NPA treated C57BL/6 mice. Aging caused an increase in damage in both nuclear and mitochondrial genomes. 3-NPA induced 4-6 more damage in mtDNA than nuclear DNA in 5-month-old mice, and this damage was repaired by 48h in the mtDNA. In 24-month-old mice 3NPA caused equal amounts of nuclear and mitochondrial damage and this damage persistent in both genomes for 48h. QPCR analysis showed a progressive increase in the levels of mtDNA damage in the striatum and cerebral cortex of 7-12-week-old R6/2 mice. Striatum exhibited eight-fold more damage to the mtDNA compared with a nuclear gene. These data suggest that mtDNA damage is an early biomarker for HD-associated neurodegeneration and supports the hypothesis that mtDNA lesions may contribute to the pathogenesis observed in HD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18935984      PMCID: PMC3268004          DOI: 10.1016/j.dnarep.2008.09.004

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  46 in total

1.  Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress.

Authors:  F M Yakes; B Van Houten
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease.

Authors:  S Palfi; R J Ferrante; E Brouillet; M F Beal; R Dolan; M C Guyot; M Peschanski; P Hantraye
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

3.  Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

Authors:  L Mangiarini; K Sathasivam; M Seller; B Cozens; A Harper; C Hetherington; M Lawton; Y Trottier; H Lehrach; S W Davies; G P Bates
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

4.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

Review 5.  The base excision repair pathway.

Authors:  E Seeberg; L Eide; M Bjørås
Journal:  Trends Biochem Sci       Date:  1995-10       Impact factor: 13.807

6.  Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

Authors:  S E Browne; A C Bowling; U MacGarvey; M J Baik; S C Berger; M M Muqit; E D Bird; M F Beal
Journal:  Ann Neurol       Date:  1997-05       Impact factor: 10.422

7.  Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.

Authors:  M F Beal; E Brouillet; B G Jenkins; R J Ferrante; N W Kowall; J M Miller; E Storey; R Srivastava; B R Rosen; B T Hyman
Journal:  J Neurosci       Date:  1993-10       Impact factor: 6.167

8.  Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity.

Authors:  J B Schulz; D R Henshaw; U MacGarvey; M F Beal
Journal:  Neurochem Int       Date:  1996-08       Impact factor: 3.921

9.  Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases.

Authors:  J B Schulz; R T Matthews; D R Henshaw; M F Beal
Journal:  Neuroscience       Date:  1996-04       Impact factor: 3.590

10.  Mitochondrial defect in Huntington's disease caudate nucleus.

Authors:  M Gu; M T Gash; V M Mann; F Javoy-Agid; J M Cooper; A H Schapira
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

View more
  52 in total

Review 1.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

2.  Huntington's disease and mitochondrial alterations: emphasis on experimental models.

Authors:  Verónica Pérez-De la Cruz; Paul Carrillo-Mora; Abel Santamaría
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

Review 3.  Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission.

Authors:  P Hemachandra Reddy
Journal:  Drug Discov Today       Date:  2014-03-28       Impact factor: 7.851

Review 4.  Oxidative genome damage and its repair: implications in aging and neurodegenerative diseases.

Authors:  Muralidhar L Hegde; Anil K Mantha; Tapas K Hazra; Kishor K Bhakat; Sankar Mitra; Bartosz Szczesny
Journal:  Mech Ageing Dev       Date:  2012-01-31       Impact factor: 5.432

5.  Age-related instability in spermatogenic cell nuclear and mitochondrial DNA obtained from Apex1 heterozygous mice.

Authors:  Kristine S Vogel; Marissa Perez; Jamila R Momand; Karina Acevedo-Torres; Kim Hildreth; Rebecca A Garcia; Carlos A Torres-Ramos; Sylvette Ayala-Torres; Thomas J Prihoda; C Alex McMahan; Christi A Walter
Journal:  Mol Reprod Dev       Date:  2011-09-14       Impact factor: 2.609

Review 6.  The role of glia in stress: polyamines and brain disorders.

Authors:  Serguei N Skatchkov; Michel A Woodbury-Fariña; Misty Eaton
Journal:  Psychiatr Clin North Am       Date:  2014-11-25

Review 7.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

8.  Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease.

Authors:  Jiu-Qiang Wang; Qian Chen; Xianhua Wang; Qiao-Chu Wang; Yun Wang; He-Ping Cheng; Caixia Guo; Qinmiao Sun; Quan Chen; Tie-Shan Tang
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

9.  DNA damage in normally and prematurely aged mice.

Authors:  Alexander Y Maslov; Shireen Ganapathi; Maaike Westerhof; Wilber Quispe-Tintaya; Ryan R White; Bennett Van Houten; Erwin Reiling; Martijn E T Dollé; Harry van Steeg; Paul Hasty; Jan H J Hoeijmakers; Jan Vijg
Journal:  Aging Cell       Date:  2013-04-24       Impact factor: 9.304

10.  Glutathione-deficient Plasmodium berghei parasites exhibit growth delay and nuclear DNA damage.

Authors:  Vivian Padín-Irizarry; Emilee E Colón-Lorenzo; Joel Vega-Rodríguez; María Del R Castro; Ricardo González-Méndez; Sylvette Ayala-Peña; Adelfa E Serrano
Journal:  Free Radic Biol Med       Date:  2016-03-04       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.